Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (32 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 Dec 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | PGIM India Midcap Fund |
|---|---|
| 05 Dec 2013 | ₹100.00 |
| 27 Dec 2014 | ₹141.36 |
| 18 Jan 2016 | ₹125.77 |
| 07 Feb 2017 | ₹150.25 |
| 01 Mar 2018 | ₹177.92 |
| 23 Mar 2019 | ₹163.74 |
| 13 Apr 2020 | ₹137.06 |
| 04 May 2021 | ₹294.31 |
| 26 May 2022 | ₹354.15 |
| 17 Jun 2023 | ₹430.67 |
| 08 Jul 2024 | ₹596.50 |
| 29 Jul 2025 | ₹622.88 |
| 20 Aug 2026 | ₹652.35 |
| Metric | PGIM India · Direct · IDCW NAV ₹65.30 Very High risk ★★★★☆ | Category median Mid Cap Fund · 32 funds |
|---|---|---|
| +2.24% | +6.29% | |
| +13.88% | +14.78% | |
| +12.88% | +13.99% | |
| +16.25% | +9.73% | |
| +15.90% | +15.68% | |
| +12.10% | — | |
| +16.74% | +16.53% | |
| +17.44% | +14.94% | |
| +15.99% | +12.00% | |
| Risk | ||
| 15.21% | 16.93% | |
| 0.48 | 0.53 | |
| 0.67 | 0.73 | |
| -39.48% | -36.26% | |
| Nifty Midcap 150 | — | |
| -2.17% | -2.10% | |
| 0.85 | 0.97 | |
| 81.3% | 93.0% | |
| 85.4% | 95.9% | |
| 0.76% | 0.95% | |
| ₹10,741Cr | ₹7,889Cr | |
| 0.50% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 110% | 40% | |
| Vivek Sharma | — | |
| 05 Dec 2013 | — | |
| 108 | — | |
| 21.7% | — | |
| 0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.